SpectraScience, Inc. (OTCQB: SCIE) (PINKSHEETS: SCIE), a San Diego

based medical device company, today announced that Chief Executive

Officer Michael Oliver will present to investors as part of the LHA

Life Sciences & Medical Technologies Virtual Conference on Thursday,

February 16, 2012, at Noon Eastern time.

A webcast of the presentation will be accessible online at the

PrecisionIR event site:

An archived version will be available for 30 days.

About SpectraScience, Inc.

SpectraScience is a San Diego based medical device company that

designs, develops, manufactures and markets light-based analysis

systems capable of determining whether tissue is normal, pre-cancerous

or cancerous without physically removing tissue from the body. The

WavSTAT Optical Biopsy System uses light to optically diagnose tissue

and provide the physician with an immediate analysis. With FDA

approval for sale in the U.S. and the CE Mark for the European Union,

the WavSTAT System is the first commercially available product that

incorporates this innovative technology for clinical use.